Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sonus Pharma (SNUS) ? Opinions -- Ignore unavailable to you. Want to Upgrade?

To: David S. who wrote (238)	2/26/1998 10:47:00 AM
From: A.J. Mullen	Respond to of 384

The news itself doesn't seem that substantial 'a few weeks' to assemble the information isn't much, although there is then the delay while the FDA considers it. Given the run-up, it's very understandable that many decided to lockin profits. The trading on pre-released information is another matter however. I wish the CEO would comment on that. It should be a scandal, but it's commonplace. Over a year ago a friend of mine who works for a big pharma was bemoaning that they often didn't do experiments that would be scientific interesting and might have commercial merit because 'if a technician doesn't come in one weekend and animals die, then this must be explained to the FDA over and over again.' He wasn't criticizing his company or the FDA; just an unfortunate fact of life. Perhaps some animals died over a weekend because a thermostat failed, or for some other reason. The FDA might request more details of such an incident.